Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma (Q43521840)

24 November 2017

title

Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma (English)

1 reference

24 November 2017

0 references

1 reference

Linda Ravenna

1

1 reference

24 November 2017

Patrizio Sale

2

1 reference

24 November 2017

Maura Di Vito

3

1 reference

24 November 2017

Andrea Russo

4

1 reference

24 November 2017

Luisa Salvatori

5

1 reference

24 November 2017

Marco Tafani

6

1 reference

24 November 2017

Emanuela Mari

7

1 reference

24 November 2017

Steno Sentinelli

8

1 reference

24 November 2017

Elisa Petrangeli

9

1 reference

24 November 2017

Michele Gallucci

10

1 reference

24 November 2017

Franco Di Silverio

11

1 reference

24 November 2017

Matteo A Russo

12

1 reference

24 November 2017

publication date

1 August 2009

1 reference

24 November 2017

1 reference

24 November 2017

volume

69

1 reference

24 November 2017

issue

11

1 reference

24 November 2017

page(s)

1245-1255

1 reference

Epidemiologic association between prostatitis and prostate cancer

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Alarmins: chemotactic activators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

The role of TLR activation in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

The role of the purinergic P2X7 receptor in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Estrogenic regulation of host immunity against an estrogen receptor-negative human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Cyclooxygenase-2 and prostate carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

The role of estrogens and estrogen receptors in normal prostate growth and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Oxygen deprivation triggers upregulation of early growth response-1 by the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

Extracellular nucleotides act through P2X7 receptors to activate NF-kappaB in osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20966

21 January 2018

Identifiers

DOI

10.1002/PROS.20966

1 reference

24 November 2017

1 reference